Silence Therapeutics plc (SLNCF)
USD 2.0
(0.0%)
USD 2.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -39.35 Million | -45.45 Million | 6.8 Million | -10.77 Million | 1.72 Million | -16.76 Million |
| Net Income | -50.31 Million | -47.36 Million | -45.85 Million | -36.04 Million | -22.87 Million | -20.52 Million |
| Depreciation & Amortization | 498 Thousand | 482 Thousand | 427 Thousand | 496 Thousand | 482 Thousand | 399 Thousand |
| Deferred income taxes | 8.36 Million | 713 Thousand | 4.41 Million | 3.01 Million | 2.3 Million | 1.81 Million |
| Stock-based compensation | 13.05 Million | 10.25 Million | 8.63 Million | 4.39 Million | 584 Thousand | 681 Thousand |
| Change in working capital | -11.66 Million | -8.26 Million | 38.84 Million | 18.65 Million | 21.08 Million | 913 Thousand |
| Other non-cash items | 706 Thousand | -1.27 Million | 347 Thousand | -1.3 Million | 138 Thousand | -39 Thousand |
| Investing Cash Flow | 16.43 Million | -16.54 Million | 8.67 Million | 9.61 Million | -15.01 Million | -4.83 Million |
| Investments in PPE | -45 Thousand | -440 Thousand | -1.33 Million | -514 Thousand | -9000.00 | -188 Thousand |
| Acquisitions | - | - | - | 4100.85 | - | 58 Thousand |
| Investment purchases | -20.66 Million | -16.12 Million | - | 668.89 Thousand | -15 Million | -5 Million |
| Sales/Maturities of investments | 36.18 Million | - | 10 Million | 10 Million | - | 319 Thousand |
| Other Investing Activities | 958 Thousand | 23 Thousand | 10 Thousand | -540.99 Thousand | -6000.00 | -19 Thousand |
| Financing Cash Flow | 25.15 Million | 43.04 Million | 30.71 Million | 15.42 Million | 5.27 Million | 341 Thousand |
| Debt repayment | -174 Thousand | -190 Thousand | -211 Thousand | -402 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 25.32 Million | 43.23 Million | 30.92 Million | 15.83 Million | 5.27 Million | 341 Thousand |
| Other Financing Activities | 25.32 Million | 43.23 Million | 30.92 Million | 15.83 Million | 5.27 Million | 341 Thousand |
| Accounts receivables | 314 Thousand | -584 Thousand | 27.48 Million | -29.3 Million | -5299.00 | 880.05 Thousand |
| Accounts payables | - | 1.75 Million | 3.25 Million | 1.78 Million | 4.05 Million | 1.45 Million |
| Inventory | - | -5.03 Million | -258.07 Thousand | -4.2 Million | -953.78 Thousand | -249.79 Thousand |
| Other working capital | -11.97 Million | -4.39 Million | 8.36 Million | 50.38 Million | 17.99 Million | -1.17 Million |
| Cash at beginning of period | 54.81 Million | 73.53 Million | 27.44 Million | 13.51 Million | 21.49 Million | 42.74 Million |
| Cash at end of period | 54.03 Million | 54.81 Million | 73.53 Million | 27.44 Million | 13.51 Million | 21.49 Million |
| Capital Expenditure | -45 Thousand | -440 Thousand | -1.33 Million | -514 Thousand | -9000.00 | -188 Thousand |
| Effect of forex changes on cash | -3.02 Million | 228 Thousand | -105 Thousand | -336 Thousand | 36 Thousand | -2000.00 |
| Net cash flow / Change in cash | -785 Thousand | -18.72 Million | 46.08 Million | 13.93 Million | -7.97 Million | -21.25 Million |
| Free Cash Flow | -39.39 Million | -45.89 Million | 5.47 Million | -11.29 Million | 1.71 Million | -16.94 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.44 Million | -3.36 Million | -14.96 Million | -50.31 Million | -10.66 Million | -12.01 Million |
| Depreciation & Amortization | 119 Thousand | 120 Thousand | 121 Thousand | 498 Thousand | 125 Thousand | 118 Thousand |
| Deferred income taxes | - | - | 940 Thousand | 8.36 Million | 179 Thousand | 312 Thousand |
| Stock-based compensation | 3.27 Million | 3.25 Million | 1.5 Million | 13.05 Million | 3.85 Million | 2.99 Million |
| Change in working capital | 10.17 Million | -15.67 Million | -1.13 Million | -11.66 Million | 3.67 Million | -6.92 Million |
| Other non-cash items | -882 Thousand | -791 Thousand | 1.66 Million | 706 Thousand | -2.03 Million | 553 Thousand |
| Investing Cash Flow | 548 Thousand | -39.03 Million | 382 Thousand | 16.43 Million | 20.62 Million | -4.7 Million |
| Investments in PPE | -67 Thousand | - | -1000.00 | -45 Thousand | -20 Thousand | 11.42 Thousand |
| Acquisitions | - | - | - | - | - | -8423.70 |
| Investment purchases | - | -39.43 Million | - | -20.66 Million | -2000.00 | -26.22 Million |
| Sales/Maturities of investments | - | - | - | 36.18 Million | 20.1 Million | 16.07 Million |
| Other Investing Activities | 615 Thousand | -39.03 Million | 383 Thousand | 958 Thousand | 546 Thousand | 5.43 Million |
| Financing Cash Flow | 847 Thousand | 105.56 Million | 9.92 Million | 25.15 Million | 12.03 Million | 3.18 Million |
| Debt repayment | -97 Thousand | - | -43 Thousand | -174 Thousand | -49 Thousand | -34 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 944 Thousand | 112.1 Million | 9.96 Million | 25.32 Million | 12.08 Million | 3.21 Million |
| Other Financing Activities | - | -6.54 Million | 9.96 Million | 25.32 Million | 12.08 Million | 3.21 Million |
| Accounts receivables | 6.29 Million | -7.91 Million | 234 Thousand | 314 Thousand | 11.86 Million | -11 Million |
| Accounts payables | - | - | - | - | 114.65 Thousand | -1.55 Million |
| Inventory | - | - | - | - | -6.09 Million | 1.84 Million |
| Other working capital | 1.24 Million | -4.35 Million | -1.36 Million | -11.97 Million | -2.2 Million | 3.79 Million |
| Cash at beginning of period | 113.05 Million | 54.03 Million | 58.81 Million | 54.81 Million | 29.72 Million | 46.73 Million |
| Cash at end of period | 109.48 Million | 113.05 Million | 54.03 Million | 54.03 Million | 58.81 Million | 29.72 Million |
| Capital Expenditure | -67 Thousand | - | -1000.00 | -45 Thousand | -20 Thousand | 11.42 Thousand |
| Effect of forex changes on cash | -155 Thousand | -12 Thousand | -3.21 Million | -3.02 Million | 1.3 Million | -531 Thousand |
| Net cash flow / Change in cash | -3.57 Million | 59.02 Million | -4.78 Million | -785 Thousand | 29.09 Million | -17.01 Million |
| Free Cash Flow | -4.88 Million | -7.49 Million | -11.86 Million | -39.39 Million | -4.89 Million | -14.94 Million |
1038
603658
MSTO
DWS
6217
BBRRF